Increasing CD4+T Cells Specific for Tuberculosis Correlate with Improved Clinical Immunity after Highly Active Antiretroviral Therapy
- 1 September 2002
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 18 (13) , 969-975
- https://doi.org/10.1089/088922202760265632
Abstract
Treatment advances have led to dramatic clinical improvements for patients with HIV-1 infection. These clinical improvements reflect treatment-related improvements in immune function, which are most striking in individuals who develop exaggerated immune inflammatory responses to occult opportunistic infections. The mechanisms accounting for these exaggerated immune responses are unknown. To gain insight into these mechanisms, we intensively studied a subject untreated for disseminated tuberculosis and HIV-1 coinfection who then began treatment for both diseases. We examined the changing frequencies of Mycobacterium tuberculosis (MTB)-specific CD4+ T cells that produced interferon γ (IFN-γ) after short-term stimulation with MTB antigen, and we compared these frequencies with those in HIV-1-seronegative subjects with and without prior exposure to MTB antigens. For the HIV-1/MTB-coinfected subject, the proportion of peripheral blood CD4+ T cells expressing MTB-specific IFN-γ was 8.6% at 11 days, 11% at 33 days, and 33% at 95 days after starting treatment for HIV-1. CD4+ IFN-γ+ T cells had a CD45RA-CD62L- (effector memory) phenotype and most coexpressed interleukin 2. Median frequencies of CD4+ IFN-γ+ T cells from six subjects without and nine subjects with prior exposure to MTB antigens were 0.06 and 0.46%, respectively. We conclude that individuals starting treatment for disseminated tuberculosis and HIV-1 coinfection can accumulate remarkably large numbers of MTB-specific CD4+ T cells in the peripheral blood. The rapid expansion of antigen-specific effector CD4+ T cells is one mechanism to explain immediate improvements in clinical immunity after HIV-1 treatment. This mechanism provides a theoretical framework to understand the unusual inflammatory responses recently reported to occur after starting HIV-1 treatment.Keywords
This publication has 35 references indexed in Scilit:
- CD4+T Cells Programmed to Traffic to Lymph Nodes Account for Increases in Numbers of CD4+T Cells Up to 1 Year after the Initiation of Highly Active Antiretroviral Therapy for Human Immunodeficiency Virus Type 1 InfectionThe Journal of Infectious Diseases, 2001
- Cytomegalovirus (CMV)–Specific CD4+T Lymphocyte Immune Function in Long‐Term Survivors of AIDS‐Related CMV End‐Organ Disease Who Are Receiving Potent Antiretroviral TherapyThe Journal of Infectious Diseases, 2001
- Effect of Potent Antiretroviral Therapy on Immune Responses toMycobacterium aviumin Human Immunodeficiency Virus–Infected SubjectsThe Journal of Infectious Diseases, 2000
- Restoration of Cellular Immunity Against Tuberculosis in Patients Coinfected With HIV-1 and Tuberculosis With Effective Antiretroviral Therapy: Assessment by Determination of CD69 Expression on T Cells After Tuberculin StimulationJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature, 1999
- Initial increase in blood CD4+ lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissuesJournal of Clinical Investigation, 1999
- HIV combination therapyAIDS, 1998
- Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency.Journal of Clinical Investigation, 1997
- Alterations in the Immune Response of Human Immunodeficiency Virus (HIV)-Infected Subjects Treated with an HIV-Specific Protease Inhibitor, RitonavirThe Journal of Infectious Diseases, 1996
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995